Antoine Papiernik is the chairman of Paris-based Sofinnova Partners, a venture capital firm that invests in startups and spinout biotech companies primarily in Europe. He spoke with Luke Timmerman, the founder and editor of Timmerman Report, a biotech industry newsletter, at BIO-Europe Spring in Barcelona about some of the cultural challenges facing startups in Europe.
